Immune checkpoint inhibitors alone or in combination for endometrial mismatch repair-deficient/MSI-high population

ESMO Open. 2024 Apr;9(4):102984. doi: 10.1016/j.esmoop.2024.102984. Epub 2024 Apr 12.
No abstract available

MeSH terms

  • DNA Mismatch Repair*
  • Endometrial Neoplasms* / drug therapy
  • Endometrial Neoplasms* / genetics
  • Female
  • Humans
  • Immune Checkpoint Inhibitors* / pharmacology
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Microsatellite Instability

Substances

  • Immune Checkpoint Inhibitors